We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Ray Therapeutics Stock

Invest in or calculate the value of your shares in Ray Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

Ray Therapeutics Stock (RATH)

Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.

About Ray Therapeutics Stock

Founded

2021

Headquarters

San Diego, CA, US

Industries

Science and Engineering, Health Care, Biotechnology

Ray Therapeutics is a company that creates novel optogenetic gene therapies for patients with blinding diseases. The company develops technology to study and learn about rare retinal diseases, allowing doctors to cure and treat inherited retinal diseases using optogenetics.

Ray Therapeutics Management

Leadership team at Ray Therapeutics

Head of Regulatory Affairs

Kathrin Schalper

Board of Directors

Tiba Aynechi

Locked Features

Join now and verify your accreditation status to gain access to:

  • Ray Therapeutics current valuation
  • Ray Therapeutics stock price
  • Available deals in Ray Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Ray Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like Ray Therapeutics through EquityZen funds. These investments are made available by existing Ray Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Ray Therapeutics stock?

Shareholders can sell their Ray Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."